This inventor holds 31 USPTO granted patents and 13 published patent applications and 4 EPO patents, primarily in Pharmaceutical Innovations. Top assignees: Enanta Pharmaceuticals, Inc., Elmore Patent Law Group, P.c.. Active years: 2014-2026.
Location History:
- Brookline, MA (US) (2014)
- Brigton, MA (US) (2017)
- Brighton, MA (US) (2015 - 2021)
- Newton, MA (US) (2021 - 2024)
Company Filing History:
Years Active: 2014-2026
Areas of Expertise:
Title: The Innovative Contributions of Bin Wang in Biopharmaceutical Patents
Introduction
Bin Wang, based in Brighton, MA, is an accomplished inventor with a remarkable portfolio of 28 patents. His work primarily focuses on biopharmaceutical innovations, particularly in the therapeutic targeting of various diseases linked to the apoptosis signal-regulating kinase 1 (ASK-1). The significance of his inventions lies in their potential to address critical health challenges, including autoimmune disorders, neurodegenerative disorders, and chronic diseases.
Latest Patents
Among his recent patents, Bin Wang has developed innovative compounds that inhibit ASK-1, aimed at treating various ASK-1 related diseases. These compounds include formulations for pharmaceutical compositions that cater to individuals suffering from conditions such as hepatic steatosis, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH). The inventions detail methods of using these compounds effectively for treatment, showcasing his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Bin Wang has contributed significantly to the biopharmaceutical field. He has worked with leading organizations, including Enanta Pharmaceuticals, Inc., where he played a pivotal role in research and development. His expertise in patent law was further honed at Elmore Patent Law Group, P.C., highlighting his multifaceted skill set that merges scientific innovation with legal acumen.
Collaborations
Bin Wang has collaborated with talented professionals such as Yat Sun Or and Guoqiang Wang, which has enriched his research and development endeavors. These collaborations have been instrumental in propelling his inventions forward and facilitating the exploration of new therapeutic avenues in the treatment of complex diseases.
Conclusion
In summary, Bin Wang's contributions to the field of biopharmaceuticals through his innovative patents reveal a dedicated inventor committed to addressing significant health issues. His work on ASK-1 inhibitors and their applications emphasizes the importance of continued research and development in creating effective treatments for complex diseases. As he progresses in his career, his impact on the medicinal chemistry landscape will undoubtedly inspire future innovations.